Earlier this week, Rocket Lab Corporation announced it had secured its largest launch contract to date, a US$266 million agreement with the U.S. Space Force for at least 12 suborbital missions, primarily launching from a new site at the Pacific Spaceport Complex-Alaska by the end of 2028.
This multi-launch defense deal expands Rocket Lab’s role in missile defense testing and strengthens its position as an integrated provider to U.S. national security programs across multiple launch sites.
We’ll now explore how this multi-year US$266 million U.S. Space Force deal could influence Rocket Lab’s investment narrative and long-term positioning.
AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.
Rocket Lab Investment Narrative Recap
To own Rocket Lab, you need to believe its move toward an end to end space platform can eventually justify today’s losses and volatility. The US$266 million U.S. Space Force contract adds revenue visibility and partially offsets the risk of “lumpy” program wins, but it does not change the near term focus on Neutron execution and cash burn. The biggest swing factor remains whether Rocket Lab can control capital intensity while converting its growing backlog into profitable growth.
The recent VICTUS HAZE rapid response mission for the U.S. Space Force is particularly relevant here. It showed Rocket Lab acting as a single prime contractor for rocket, spacecraft and on orbit operations, which aligns directly with the new multi launch defense deal. Together, they highlight how national security programs can reinforce the end to end solutions thesis, while also increasing dependence on timely government awards and complex, mission critical execution.
Yet even with these contracts, investors should be aware that growing dependence on large, technically complex defense programs could…
Read the full narrative on Rocket Lab (it’s free!)
Rocket Lab’s narrative projects $1.8 billion revenue and $169.1 million earnings by 2029.
Uncover how Rocket Lab’s forecasts yield a $114.33 fair value, a 79% upside to its current price.
Exploring Other Perspectives 
RKLB 1-Year Stock Price Chart
Some of the lowest ranked analysts on Rocket Lab were already cautious, assuming revenue of about US$1.7 billion and only US$14.8 million in earnings by 2029, and worrying that vertical integration and M&A might compress margins instead of lifting them. With the new Space Force deal in hand, it will be important to see whether those more pessimistic views on execution risk and profitability shift, or whether they stay skeptical while others grow more optimistic.
Explore 32 other fair value estimates on Rocket Lab – why the stock might be worth less than half the current price!
Reach Your Own Conclusion
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
No Opportunity In Rocket Lab?
Markets shift fast. These stocks won’t stay hidden for long. Get the list while it matters:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include RKLB.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com